Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol prophylaxis for anthracycline-induced cardiomyopathy in breast cancer
IRCT20130701013828N8Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of bisoprolol in Anthracycline Cardiomyopathy (2 arms), sponsored by Islamic Azad University. Primary endpoints: Left ventricular end-diastolic volume, Left ventricular end-systolic volume and 3 more. Started Oct 2021; status: completed.
02
Drugs
bisoprolol
03
Conditions
Anthracycline Cardiomyopathy
Beyond the preview
Go deeper on IRCT20130701013828N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130701013828N8.